Supernus Pharmaceuticals Inc. (NASDAQ: SUPN) completed its acquisition of Sage Therapeutics Inc. (NASDAQ: SAGE) on July 31, 2025, following the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE